ESTIMATION OF THE EFFECTIVENESS OF FINANCIAL COSTS FOR TARGETED THERAPY OF PATIENTS WITH METASTATIC KIDNEY CANCER. Voprosy onkologii, v. 64, n. 5, p. 657–663, 1 May2018.